Minerva Neurosciences

IPO

Minerva Neurosciences is a biotech company in Waltham, United States, founded in 2007. It has raised $220.0M across 3 rounds, most recently a $200.0M Venture Round in October 2025.

A New Approach to Schizophrenia Treatment

Employees
11–50
Founded
2007
Business Model
B2B
Total Funding
$220.0M
Last Round
$200.0M Venture RoundOct 2025
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders. Founded in 2007 and headquartered in Waltham, Massachusetts, the company has built its pipeline by identifying, acquiring, and in-licensing proprietary development-stage compounds with innovative mechanisms of action. Its lead product candidate, roluperidone, is being developed as a potential first-in-class treatment for negative symptoms in patients with schizophrenia. The company's strategy centers on leveraging randomized clinical trial data to advance candidates across multiple regulatory jurisdictions while selectively exploring collaborations with major pharmaceutical partners to maximize program value.

Summary

It lists 11–50 employees. It has raised $220.0M in total across 3 rounds, most recently a $200.0M Venture Round in Oct 2025. Investors include Janus Henderson Investors.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundOct 2025
$200.0M

Sign up to see all 3 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Minerva Neurosciences on Indexed.vc
<a href="https://indexed.vc/companies/minerva-neurosciences"><img src="https://indexed.vc/api/badge/company/minerva-neurosciences" alt="Minerva Neurosciences on Indexed.vc" width="260" height="76" /></a>